Shorten your time to market in drug development

Biomarkers are important when it comes to the development of novel drugs and mechanisms and are also gaining importance as companion diagnostic markers.

Indivumed provides extensive R&D services for biomarker assay development and clinical validation and to develop biomarkers that accurately indicate improved clinical outcomes. Our access to ischemia-controlled biospecimen as well as pathology-grade “real-life” samples shorten your time to market.

The service ranges from characterization and validation of commercial or proprietary antibodies to clinical verification and validation of the established assays. In-house pathologists create read-outs using state-of-the-art digital histopathology to provide robust results. Our biomarker analysis and development program is designed according to ISO certification, GCLP compliance, and ICH guidelines.

IndivuServ serves as a partner for clinical trials, which includes both the collection of biospecimen from cancer patients as well as performing analytical assays in Indivumed’s GCLP-compliant laboratories.

Discover our range of products and services